Amgen Inc. has terminated its collaboration with Bay area startup Cytokinetics.
MannKind Corp. in Westlake Village has received its final $12.5 million milestone payment from United Therapeutics.
California Lutheran University in Thousand Oaks will offer a minor in public health starting in January
Drug modeling software company Simulations Plus Inc. enjoyed an increase in revenue compared to last year, while earnings per share remained flat for the fourth financial quarter.
Ventura County has dropped to the most restrictive COVID-19 reopening framework tier.
Medical device giant Medtonic has launched InPen, the first FDA-cleared smart insulin pen for diabetes patients needing multiple daily injections.
Providence Southern California has joined Anthem Blue Cross’s Vivity Health Plan as a joint venture partner.
MannKind Corp. missed third-quarter earnings estimates by 1 cent, but enjoyed a net revenue increase for its flagship drug, inhalable insulin Afrezza.
Valley Home Medical Supply Inc. in Canoga Park paid a $565,873 settlement after allegations arose that the company defrauded the federal government's Medicare and Tricare programs.
Providence Cedars-Sinai Tarzana Medical Center held a “topping out” ceremony for its new patient tower.
Amgen Inc. exceeded analysts estimates for the third quarter, based on results announced by the company.
Infusion provider Infusion for Health, based in Thousand Oaks, announced Dan McCarty as its new chief executive.
Lancaster drug simulation company Simulations Plus has won a $1.2 million grant from the U.S. Food and Drug Administration to test the efficacy of oral cavity products.
Valley hospitals were required to spend in preparation for a surge of COVID patients that didn’t materials.
A2 Biotherapeutics in Agoura Hills closed its Series B round of financing at $71.5 million.